Biotech Values

[DewDiligence]

New Survey: When Will FDA Approve First Biosimilar/Biogeneric?

Definitions for this survey:

• A biosimilar is a non-substitutable biologic drug whose approval is based, in part, on the safety and efficacy dossier of the corresponding branded drug.

• A biogeneric is a biologic that is fully substitutable by a pharmacist or hospital formulary for the corresponding branded drug.

(Please see #msg-48581353 for provisions of the recently enacted law that empowers the FDA to approve biosimilars and biogenerics.)


Q1: When will FDA approve the first biosimilar?
a) 2010
b) 2011
c) 2012 or later
d) Never


Q2: When will FDA approve the first biogeneric?
a) 2010
b) 2011
c) 2012 or later
d) Never


To vote, go to
http://www.investorshub.com/boards/board_surveymenu.asp?board_id=1418
and select survey #132.